Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel C. Adelman
Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Longer-Term Safety and Efficacy Measures of AR101 Oral Immunotherapy for Peanut Allergy: Results From a Phase 3 Follow-On Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?
Nature Reviews Immunology
Medicine
Allergy
Immunology
Sterile Inflammation: Sensing and Reacting to Damage
Nature Reviews Immunology
Medicine
Allergy
Immunology
DAMP-driven Metabolic Adaptation
Nature Reviews Immunology
Medicine
Allergy
Immunology
The Regulation of IL-10 Production by Immune Cells
Nature Reviews Immunology
Medicine
Allergy
Immunology
Complement as a Target in COVID-19?
Nature Reviews Immunology
Medicine
Allergy
Immunology
The Function of Fcγ Receptors in Dendritic Cells and Macrophages
Nature Reviews Immunology
Medicine
Allergy
Immunology
Monocyte Recruitment During Infection and Inflammation
Nature Reviews Immunology
Medicine
Allergy
Immunology
Signalling Pathways That Control Vertebrate Haematopoietic Stem Cell Specification
Nature Reviews Immunology
Medicine
Allergy
Immunology
Heat Shock Proteins Are No DAMPs, Rather 'DAMPERs'
Nature Reviews Immunology
Medicine
Allergy
Immunology
Standardization in Flow Cytometry: Correct Sample Handling as a Priority
Nature Reviews Immunology
Medicine
Allergy
Immunology
